Accelerating pharma's digital IQ as customer engagement evolves

on demand

The COVID-19 pandemic has brought many changes to the pharmaceutical industry, among them how companies can continue to engage with healthcare professionals (HCPs) and other stakeholders.

Digital channels are vital for the pharma industry. The coronavirus emergency has created a pivot point to the next normal as the life sciences continues to accelerate its move to digital and virtual engagement.

At this time of rapid change companies need to accelerate the evolution of their engagement efforts by improving their ‘digital IQ’, which is the ability to deliver a personalised customer experience based on the right virtual channel mix, field force soft skills, and data & content powered interactions.


The Accelerating your digital IQ for the next normal of customer engagement webinar, in association with Veeva, took place on Thursday 25th June from 15:00 to 16:00 (BST) / 16:00 to 17:00 (CEST) and looked at a new engagement model for the post-COVID era.

Our expert panel discussed:

  • Real-world insights of how pharma is already adapting
  • Current trends in the field engagement model
  • Market observations from before and during the COVID crisis
  • How pharmaceutical companies can increase their digital IQ and accelerate the move to digital

You can view the on demand webinar* in the window above or by clicking here.

Our panel

David Logue, SVP Commercial Strategy, Europe, VeevaDavid Logue, SVP Commercial Strategy, Europe, Veeva

David Logue is Veeva’s senior vice president of commercial strategy and is responsible for the strategy of Veeva Commercial Cloud in Europe. Before Veeva, David spent more than 20 years at Accenture delivering digital strategy projects and large-scale business transformation programs, focused in the pharmaceutical and healthcare industry. He aims to leverage his experience to bring a broad perspective of how an effective digital and data strategy can be truly transformative in the life sciences industry.

Aaron Bean, Veeva Business Consulting Leader, EuropeAaron Bean, Business Consulting Leader, Europe, Veeva

Aaron Bean is Veeva's European business consulting lead. He has over 17 years of consulting experience, having previously worked at Accenture and more recently at EY for the past 13 years where he led the UK&I Life Sciences consulting practice. Aaron's areas of expertise and passion lie in helping Life Sciences companies navigate and deliver commercial transformation and innovation programs to improve their customer experience and deliver better outcomes for patients. At Veeva Business Consulting, Aaron is building a different type of consulting practice that offers commercial strategy through to execution services, leveraging leading technology platforms, assets, and proprietary data to deliver tangible and sustainable value at speed for customers.

Sierra TowersSierra Towers, Global Head of Multichannel Excellence, Boehringer Ingelheim

Sierra Towers has over ten years of experience in the healthcare/pharmaceutical industry. Sierra has spent most of her time in pharma in the US in leadership roles in brand marketing with a focus on enhancing digital engagement opportunities. Over the past two years, Sierra has been working out of the corporate office in Germany leading the Multichannel team responsible for identifying and building platforms and technologies to support omni-channel orchestration across all customer groups and markets.

Dominic-TyerDominic Tyer, Interim Managing Editor, pharmaphorum [moderator]

Dominic Tyer is a trained journalist and editor with 19 years of pharmaceutical and healthcare publishing experience. He serves as interim managing editor at pharmaphorum media, which facilitates productive engagement for pharma, bringing healthcare together to drive medical innovation. He is also creative and editorial director at the company’s specialist healthcare content consultancy, pharmaphorum connect.

Further speakers to be announced shortly.